O-025

Oxcarbazepine solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Manufacturer: Supelco

CAS Number: 28721-07-5

Select a Size

Pack Size SKU Availability Price
1 ML O-025-1-ML In Stock ₹ 11,531.10

O-025 - 1 ML

₹ 11,531.10

In Stock

Quantity

1

Base Price: ₹ 11,531.10

GST (18%): ₹ 2,075.598

Total Price: ₹ 13,606.698

grade

certified reference material

Quality Level

300

form

liquid

feature

Snap-N-Spike®/Snap-N-Shoot®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

concentration

1.0 mg/mL in acetonitrile

technique(s)

gas chromatography (GC): suitableliquid chromatography (LC): suitable

application(s)

clinical testing

format

single component solution

Other Options

Related Products

Img

Supelco

O-024

1.0 mg/mL in acetonitrile, ampule o...

Img

Supelco

P-109

100 μg/mL in acetonitrile, certifie...

Img

Supelco

P-123

100 μg/mL in acetonitrile, certifie...

Img

Supelco

P-124

100 μg/mL in acetonitrile, certifie...

Img

Supelco

P-045

1.0 mg/mL in methanol, ampule of 1 ...

Description

  • General description: Oxcarbazepine, marketed under the trade name Trileptal®, is an anticonvulsant developed and prescribed for treatment of epilepsy. In recent years, Oxcarbazepine has shown efficacy in treatment of mood disorders. This certified solution standard is suitable as starting material for the preparation of calibrators and controls in oxcarbazepine testing by GC/MS or LC-MS/MS.
  • Application: Quantitative analysis for therapeutic monitoring: Oxcarbazepine solution is utilized in liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods for the quantitative analysis of drug levels in patients undergoing epilepsy treatment. This approach aids in therapeutic drug monitoring, ensuring drug efficacy and safety (Johnson-Davis and Thomas, 2024).Advanced detection techniques: Research integrates Raman spectroscopy and convolutional neural networks for the detection of antiepileptic drug concentrations, including Oxcarbazepine. This technology enhances the precision of drug measurement, vital for managing and controlling seizures in neurological disorders (Fu et al., 2023).Environmental impact studies: Studies on the degradation of Oxcarbazepine by bromate in water under sunlight irradiation provide critical data on the environmental behavior of this pharmaceutical. Understanding its environmental breakdown helps in assessing the ecological impact and designing better waste management strategies (Sun et al., 2023).
  • Legal Information: CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFETY INFORMATION

Pictograms

GHS02,GHS07

Signal Word

Danger

Hazard Statements

H225,H302 + H312 + H332,H319

Precautionary Statements

P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P305 + P351 + P338

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2

WGK

WGK 2

Flash Point(F)

35.6 °F

Flash Point(C)

2 °C